Roze AI is listed on the Nasdaq Capital Market under the ticker symbol “RZAI.”
This website contains forward-looking statements, including statements regarding Roze AI’s product development plans and business strategy. Forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including regulatory review and market conditions. Any offering of securities will be made only by means of a prospectus filed with the U.S. Securities and Exchange Commission. Nothing on this website constitutes an offer to sell or a solicitation of an offer to buy securities in any jurisdiction. Roze AI undertakes no obligation to update forward-looking statements except as required by law.
Forward-Looking Statements Disclaimer: This Investor Relations section contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements that are not historical facts, including statements about beliefs and expectations, are forward- looking statements. These statements involve inherent risks and uncertainties, and actual results may differ materially from those contained in any forward-looking statement. For more detailed information regarding risk factors, please refer to ROZE AI INC.’s Registration Statement on Form F-1/A filed with the U.S. Securities and Exchange Commission.
RozeAI Inc. is a Foreign Private Issuer and Emerging Growth Company under SEC rules, entitled to rely on specific governance and disclosure exemptions under Nasdaq Rule 5615(a)(3) and the JOBS Act. Regulatory filings are accessible via SEC EDGAR